Clinical experience and speculation on the treatment of end-stage heart failure with a domestic HeartCon implantable left ventricular assist device
10.3760/cma.j.cn112434-20221005-00316
- VernacularTitle:国产HeartCon型植入式左心室辅助装置治疗终末期心力衰竭的经验与思辨
- Author:
Xiaocheng LIU
1
Author Information
1. 泰达国际心血管病医院心脏外科，天津 300457
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2023;39(5):283-290
- CountryChina
- Language:Chinese
-
Abstract:
The author, as a coordinating investigator, jointly with the other ten PIs conducted a 62-case multicenter clinical trial of a domestic HeartCon implantable left ventricular assist device(LVAD) for the treatment of end-stage heart failure(ESHF), the results of which demonstrated the safety and efficacy of the device. In the clinical practice, we have not only validated the international general knowledge, but also created some ideas and methods that are different from the international traditional practice and has been proved to be more reasonable by repeated practice. We hereby would like to share our experience and speculation, so as to provide the reference for the colleagues.
